(Q40824653)

24 September 2017

1 reference

title

Aldose reductase inhibitors: an update (English)

1 reference

24 September 2017

S C Tsai

1

1 reference

24 September 2017

T G Burnakis

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

751-754

1 reference

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700616

Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700616

Recent clinical experience with aldose reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700616

Effects of aldose reductase inhibitors on the progression of nerve fiber damage in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700616

Long-term effects of tolrestat on symptomatic diabetic sensory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700616

10.1177/106002809302700616

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference